课题基金 / 基金详情

25% ERROR RATE IN SEROLOGIC TYPING OF HLA B HOMOZYGOTES

25% ERROR RATE IN SEROLOGIC TYPING OF HLA B HOMOZYGOTES
25%%20ERROR%20RATE%20IN%20SEROLOGIC%20TYPING%20OF%20HLA%20B%20纯合子
批准号:
6277725
负责人:
David I Watkins
金额:
$5.14万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 1999-04-30

项目摘要

项目成果

David I Watkins的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The microlymphocytotoxicity technique has been the accepted method for HLA class I typing since the early 1960s. However, it is often difficult to distinguish two related alleles expressed in an individual due to the cross-reactive nature of the alloantibodies used in this technique. This is especially evident at the HLA-B locus, whose more than 180 alleles fall into only 4 major interrelated cross-reactive antigen groups. To estimate the error rate in serologic typing due to the cross-reactive nature of sera, we used polymerase chain reaction with sequence-specific primers (PCR-SSP) amplification to retype 40 individuals who were previously typed as serologic HLA-B locus homozygotes. OBJECTIVE: To estimate the error rate in serologic typing due to the cross-reactive nature of sera. RESULTS PCR-SSP revealed that 10 of these 40 individuals (25%) were actually heterozygous at their HLA-B loci. The HLA-B locus alleles of these 10 discrepant individuals were further analyzed by denaturing gradient gel electrophoresis followed by direct sequencing. The sequence analysis confirmed that all nine individuals were indeed HLA-B locus heterozygotes. FUTURE DIRECTIONS This surprisingly high error rate in serologic definition of HLA-B molecules argues for the use of rapid DNA-based techniques in HLA class I typing, even in the setting of solid organ transplantation. KEY WORDS cross-reaction, HLA-B, DGGE, homozygote, microlymphocytotoxicity, PCR-SSP, serology
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
  • 批准号:
    10669613
  • 项目类别:
  • 资助金额:
    $97.87万
  • 财政年份:
    2021
  • 负责人:
    David I Watkins
  • 依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
  • 批准号:
    10422995
  • 项目类别:
  • 资助金额:
    $99.94万
  • 财政年份:
    2021
  • 负责人:
    David I Watkins
  • 依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
  • 批准号:
    10463875
  • 项目类别:
  • 资助金额:
    $98.85万
  • 财政年份:
    2021
  • 负责人:
    David I Watkins
  • 依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
海外基金